Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM-free AIM

BACKGROUND: Recent increases in the number of patients with non-alcoholic steatohepatitis (NASH) warrant the identification of biomarkers for early detection of hepatocellular carcinoma (HCC) associated with NASH (NASH-HCC). IgM-free apoptosis inhibitor of macrophage (AIM), which generally associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Tomo, Sawada, Takashi, Asai, Tomohide, Kanetsuki, Yuka, Hirota, Jiro, Moriguchi, Michihisa, Nakajima, Tomoaki, Miyazaki, Toru, Okanoue, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858287/
https://www.ncbi.nlm.nih.gov/pubmed/34981443
http://dx.doi.org/10.1007/s12328-021-01567-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858287/
https://www.ncbi.nlm.nih.gov/pubmed/34981443
http://dx.doi.org/10.1007/s12328-021-01567-4

Ejemplares similares